Advancing patient care through rigorous, ethical, and innovative clinical trial methodologies across oncology, neurology, immunology, and rare diseases.
The Zenth Clinical Research Network (ZCRN) operates a globally integrated infrastructure for clinical investigation, spanning 142 accredited sites across 38 countries. Our multidisciplinary teams leverage adaptive trial designs, decentralized methodologies, and AI-driven patient matching to accelerate therapeutic discovery while maintaining uncompromising ethical standards.
From early-phase pharmacokinetic studies to large-scale Phase IV post-market surveillance, ZCRN bridges the gap between laboratory innovation and clinical application, ensuring regulatory excellence and measurable patient impact.
Randomized, double-blind, placebo-controlled multicenter study evaluating survival outcomes and immune response markers in NSCLC patients.
Dose-escalation study assessing neurocognitive preservation and amyloid-beta clearance via intrathecal vector administration.
Real-world evidence collection tracking long-term tolerability, functional outcomes, and caregiver quality-of-life metrics across pediatric cohorts.
All ZCRN operations adhere to international regulatory frameworks and institutional review board (IRB) oversight. We maintain full transparency through decentralized audit trails and blockchain-verified data logging.